The Japan topical pain relief market was valued at USD 540.92 Million in 2025, driven by the rising arthritis prevalence in the region. The market is anticipated to grow at a CAGR of 4.90% during the forecast period of 2026-2035, with the values likely to reach USD 872.75 Million by 2035.
Base Year
Historical Period
Forecast Period
In March 2021, Hisamitsu America launched Salonpas arthritis pain relief gel with FDA-approved diclofenac, strengthening the topical pain relief market. This initiative promotes non-invasive, evidence-based treatments, driving growth and offering alternatives to oral medications.
Several trends in the market are the growing aging population, a preference for non-pharmacological treatments, and advancements in transdermal delivery systems and nanotechnology, enhancing product efficacy and accessibility.
The key players are increasingly investing in innovative formulations, such as gels and patches, which are expected to elevate the market value.
Compound Annual Growth Rate
4.9%
Value in USD Million
2026-2035
*this image is indicative*
Topical pain relief involves the application of creams, gels, or patches directly to the skin to relieve localized pain, offering targeted treatment with minimal systemic effects. It is widely used for conditions such as arthritis, muscle aches, and minor injuries. In Japan, the topical pain relief market is growing steadily, supported by an aging population, rising musculoskeletal conditions, and a strong preference for non-invasive therapies.
Rising Rheumatoid Arthritis Prevalence to Support the Market Expansion
The increasing incidence of rheumatoid arthritis (RA) is significantly driving the growth of the topical pain relief market in Japan. In March 2024, a health report revealed that the estimated prevalence of RA in Japan is approximately 825,000 people, accounting for nearly 0.65% of the population. This rising patient base is expected to boost demand for effective topical therapies, supporting market expansion.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Drug Class
Market Breakup by Formulation
Market Breakup by Packaging Types
Market Breakup by Distribution Channel
Segmentation Based on Drug Class Holds a High Market Value
Based on the drug class, the market is divided into opioids and non-opioids. Non-opioid topical pain relief products are expected to lead the market, driven by growing concerns over opioid misuse and increasing preference for safer, non-addictive alternatives. These products offer effective pain management with reduced risk, appealing to a broader consumer base.
The Creams and Ointments Segments to Propel Japan Topical Pain Relief Market Growth
The market is segmented into creams and ointments, gels, liquid/oil, patches, sprays, and other formulations. Creams and ointments are expected to dominate the market due to their versatility, ease of application, and effectiveness in delivering localized pain relief. These formulations are preferred for various pain conditions and have a well-established consumer base.
The Tubes Packaging Type Segmentation to Lead the Market
The market, based on the packaging type, is categorized into tubes, containers and jars, aerosol containers, dermal patches, and roll-on bottles. Tubes are anticipated to lead the market, as they are convenient, portable, and easy to use for both consumers and healthcare professionals. Their ability to provide accurate doses and hygienic application enhances their popularity.
Segmentation by Distribution Channel to Shape the Japan Topical Pain Relief Market
Hospital pharmacies, retail pharmacies, online pharmacies, and others together make up the distribution channel. Online pharmacies are expected to lead the market, driven by the growing trend of e-commerce and the convenience of home delivery. This channel is gaining traction due to its accessibility, competitive pricing, and ease of purchasing.
The topical pain relief market in Japan shows regional variation, with the largest demand concentrated in urban areas like Tokyo and Osaka due to higher health awareness and access to healthcare. Rural regions exhibit steady growth, driven by the aging population and increasing preference for convenient, non-invasive pain management. Regional differences highlight varying healthcare accessibility and local preferences for topical treatments.
The key features of the market report comprise patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Kobayashi Pharmaceutical Co., Ltd., headquartered in Osaka, Japan, was established in 1886. The company is actively involved in the topical pain relief market with products like Ammeltz, a topical anti-inflammatory pain reliever, and disposable body warmers used for soothing aches and pains. Kobayashi continually innovates to meet the growing demand for localized, non-invasive pain management solutions.
Haleon Group was established in 2019 and is headquartered in Weybridge, United Kingdom. In the topical pain relief market, Haleon is active through leading brands like Voltaren, a widely recognized anti-inflammatory gel. The company’s strong focus on science-based, consumer-trusted products reinforces its growing role in addressing localized pain management needs.
Bayer AG is actively involved in the topical pain relief market. It is headquartered in Leverkusen, Germany, and was established in 1863. Its products, including AleveX topical solutions and Aspirin, address minor arthritis, back, and neck pain. Bayer’s focus on innovative, non-invasive pain relief solutions aligns with Japan's growing demand for effective and accessible topical treatments.
Hisamitsu Pharmaceutical Co., Inc., established in 1847 and headquartered in Tosu, Japan, is a leading player in the Japan topical pain relief market. Its flagship product, Salonpas, a topical analgesic patch, is recognized globally, with a significant market share. Hisamitsu also offers a variety of over-the-counter pain relief products like Nobinobi Salonsip and Air Salonpas, as well as prescription transdermal analgesics, enhancing its presence in both local and international markets.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Johnson & Johnson Services Inc., Pfizer Inc., Sanofi, Reckitt Benckiser Group, Novartis AG, and Taiho Pharma.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Formulation |
|
| Breakup by Packaging Type |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share